ASBPW

Aspire Biopharma Warrant
ASBPW

30 hedge funds and large institutions have $259K invested in Aspire Biopharma Warrant in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 2 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more ownership

Funds ownership: →

more funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $
Holders
30
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$8K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6.21K
2
+$3.17K
3
+$2.79K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.73K
5
WAM
Wolverine Asset Management
Illinois
+$36

Top Sellers

1
-$46.7K
2
-$13.4K
3
-$6K
4
JP Morgan Chase
JP Morgan Chase
New York
-$4.47K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
26
Susquehanna International Group
Pennsylvania
$1.73K
BOCH
27
Blue Owl Capital Holdings
New York
$1.5K
PMAM
28
Picton Mahoney Asset Management
Ontario, Canada
$1K
OAC
29
OMERS Administration Corp
Ontario, Canada
$747
Osaic Holdings
30
Osaic Holdings
Arizona
$1
TCA
31
Taconic Capital Advisors
New York
–
AC
32
Athos Capital
Hong Kong
–
1
2